Login to Your Account

Study: Aligning EMA, HTA facilitates process, but clarity needed

By Nuala Moran
Staff Writer

Friday, June 27, 2014
LONDON – The EMA published the conclusions of a first attempt to bring its pan-European assessments of absolute efficacy into line with the needs of national health technology assessment (HTA) bodies that are responsible for making judgements on relative efficacy of drugs, to feed into reimbursement decisions at a member state level.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription